Guideline document
This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.
Pheochromocytoma and Paraganglioma PDQ®
Topic overview
Comprehensive clinical reference from NCI covering diagnosis, staging, and treatment approaches for childhood pheochromocytoma and paraganglioma. Provides evidence-based guidance for managing these rare catecholamine-secreting neuroendocrine tumors in pediatric patients.
Key Takeaways
- Pheochromocytomas arise from adrenal medulla; paragangliomas from extra-adrenal chromaffin tissue—both secrete catecholamines.
- Pediatric cases often present with sustained hypertension, headache, sweating, and palpitations due to excess catecholamine release.
- Genetic syndromes (MEN2, VHL, NF1, SDH mutations) account for majority of pediatric cases—family history and genetic testing crucial.
- Preoperative alpha-blockade essential to prevent hypertensive crisis during surgical resection, the primary curative treatment.
- Malignant potential exists; long-term surveillance required for metastatic disease and recurrence, especially in syndromic cases.
Keywords
Hashtags
Full guideline text
Full text not available for this guideline
How to cite: GlobalCastMD. Pheochromocytoma and Paraganglioma PDQ®. GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/2388
Comments